Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer

International Journal of Gynecological Cancer

Volumn 24, Issue 4, 2014, Pages 773-778

  Van Beekhuizen, Heleen J ^a   Auzin, Maria ^b   Van Den Einden, Loes C G ^c   De Hullu, Johanna A ^c   Van Der Velden, Jacobus ^d   Wildhagen, Mark F ^a   Van Doorn, Helena C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ZNA Middelheim   (Belgium)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Groin recurrences; Inguinofemoral lymphadenectomy; Squamous cell carcinoma; Vulvar cancer

Indexed keywords

ADULT; AGED; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; INGUINAL REGION; INGUINOFEMORAL LYMPHADENECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK FACTOR; TUMOR DIFFERENTIATION; VERY ELDERLY; VULVA CANCER; VULVA CARCINOMA; VULVAR SQUAMOUS CELL CARCINOMA; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; FEMUR; FOLLOW UP; INGUINAL CANAL; LYMPH NODE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR INVASION; VULVAR NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FEMUR; FOLLOW-UP STUDIES; GROIN; HUMANS; INGUINAL CANAL; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VULVAR NEOPLASMS;

EID: 84900457301     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000125     Document Type: Review

References (18)

1. Fuh KC, Berek JS. Current management of vulvar cancer. Hematol Oncol Clin North Am. 2012;26:45-62.
2. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884-889.
3. Levenback CA, Coleman S, Gold RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30:3786-3791.
4. Butler JS, Milliken DA, Dina R, et al. Isolated groin recurrence in vulval squamous cell cancer (VSCC). The importance of node count. Eur J Gynaecol Oncol. 2010;31:510-513.
5. Cormio G, Loizzi V, Carriero C, et al. Groin recurrence in carcinoma of the vulva: management and outcome. Eur J Cancer Care (Engl). 2010;19:302-307.
6. Courtney-Brooks M, Sukumvanich P, Beriwal S, et al. Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease? Gynecol Oncol. 2010; 117:308-311.
7. Stehman FB, Ali S, DiSaia PJ. Node count and groin recurrence in early vulvar cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2009;113:52-56.
8. Gordinier ME, Malpica A, Burke TW, et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003; 90:625-628.
9. Stehman FB, Bundy BN, Dvoretsky PM, et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992;79:490-497.
10. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet. 2009;105:105-106.
11. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105:103-104.
12. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol. 1983;16:179-189.
13. Homesley HD, Bundy BN, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol. 1993;49:279-283.
14. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155-159.
15. Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327-334.
16. Boyce J, Fruchter RG, Kasambilides E, et al. Prognostic factors in carcinoma of the vulva. Gynecol Oncol. 1985; 20:364-377.
17. Shimm DS, Fuller AF, Orlow EL, et al. Prognostic variables in the treatment of squamous cell carcinoma of the vulva. Gynecol Oncol. 1986;24:343-358.
18. Cormier B, Sauthier P, Lussier C, et al. Determinants of lymph node count in endometrial cancer surgical staging. Int J Gynecol Cancer. 2012;22:1361-1366.